http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-108412-U
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2016-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-108412-U |
| titleOfInvention | METHOD OF REDUCING ULCEROGENIC ACTION OF NON-steroidal Anti-inflammatory Drugs in Experimental Models in Rats |
| abstract | A method of reducing the ulcerogenic action of non-steroidal anti-inflammatory drugs in experimental models in rats involves the use of an anti-inflammatory compound that promotes the release of HS. 4-thiazolidinone derivative - compound Les-5054 [5- (3,5-di-tert-butyl-4-hydroxy-benzylidene) -2-thioxo-thiazolidin-4-one] is administered to experimental animals at a dose of 10 mg / kg orally. , daily for 3 days against the background of the destructive lesions caused by the administration of indomethacin at a dose of 35 mg / kg subcutaneously for 72 hours. |
| priorityDate | 2016-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 14.